338 related articles for article (PubMed ID: 187701)
1. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
3. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
Mills BJ; Beebe DP; Cooper NR
J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunostimulation. IV. Role of complement.
Shearer WT; Atkinson JP; Frank MM; Parker CW
J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
6. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
Nikiforova TV; Kuznetsova NN; Vavilova LM
Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
[No Abstract] [Full Text] [Related]
8. Testing of hemolytic complement components in domestic animals.
Barta O; Hubbert NL
Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.
Mills BJ; Cooper NR
J Immunol; 1978 Oct; 121(4):1549-57. PubMed ID: 212482
[No Abstract] [Full Text] [Related]
10. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
Peters DK; Williams DG
Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
[No Abstract] [Full Text] [Related]
11. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
13. The complement system and nephritis.
Müller-Eberhard HJ
Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
[No Abstract] [Full Text] [Related]
14. The functional significance of complement.
Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
[No Abstract] [Full Text] [Related]
15. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs.
Böttger EC; Hoffmann T; Hadding U; Bitter-Suermann D
J Immunol; 1985 Dec; 135(6):4100-7. PubMed ID: 2933459
[TBL] [Abstract][Full Text] [Related]
16. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
18. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
19. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
